MARKET

PODD

PODD

Insulet Corp
NASDAQ
220.44
+4.44
+2.05%
Opening 11:42 03/26 EDT
OPEN
216.00
PREV CLOSE
216.00
HIGH
221.11
LOW
215.62
VOLUME
396.87K
TURNOVER
--
52 WEEK HIGH
354.88
52 WEEK LOW
215.26
MARKET CAP
15.52B
P/E (TTM)
63.36
1D
5D
1M
3M
1Y
5Y
1D
Insulet Corp. Stock Slips 4.2%, Underperforms Peers
Dow Jones · 19h ago
Insulet Corp. stock underperforms Wednesday when compared to competitors
MarketWatch · 19h ago
Insulet Trials Closed Loop Pod For Type 2 Diabetes As Shares Lag
Simply Wall St · 1d ago
Is Insulet (PODD) Pricing Reflect Its Recent Share Pullback And DCF Implied Upside Potential
Simply Wall St · 2d ago
Weekly Report: what happened at PODD last week (0316-0320)?
Weekly Report · 3d ago
Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Novartis in focus
Seeking Alpha · 4d ago
Is Insulet Stock Underperforming the Dow?
Barchart · 5d ago
Should You Continue to Hold Insulet Stock in Your Portfolio?
NASDAQ · 5d ago
More
About PODD
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.

Webull offers Insulet Corp stock information, including NASDAQ: PODD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PODD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PODD stock methods without spending real money on the virtual paper trading platform.